Department of Surgery, Johns Hopkins School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.
Liver Transpl. 2012 Jun;18(6):621-9. doi: 10.1002/lt.23416.
Approximately 14,000 women of reproductive age are currently living in the United States after liver transplantation (LT), and another 500 undergo LT each year. Although LT improves reproductive function in women with advanced liver disease, the associated pregnancy outcomes and maternal-fetal risks have not been quantified in a broad manner. To obtain more generalizable inferences, we performed a systematic review and meta-analysis of articles that were published between 2000 and 2011 and reported pregnancy-related outcomes for LT recipients. Eight of 578 unique studies met the inclusion criteria, and these studies represented 450 pregnancies in 306 LT recipients. The post-LT live birth rate [76.9%, 95% confidence interval (CI) = 72.7%-80.7%] was higher than the live birth rate for the US general population (66.7%) but was similar to the post-kidney transplantation (KT) live birth rate (73.5%). The post-LT miscarriage rate (15.6%, 95% CI = 12.3%-19.2%) was lower than the miscarriage rate for the general population (17.1%) but was similar to the post-KT miscarriage rate (14.0%). The rates of pre-eclampsia (21.9%, 95% CI = 17.7%-26.4%), cesarean section delivery (44.6%, 95% CI = 39.2%-50.1%), and preterm delivery (39.4%, 95% CI = 33.1%-46.0%) were higher than the rates for the US general population (3.8%, 31.9%, and 12.5%, respectively) but lower than the post-KT rates (27.0%, 56.9%, and 45.6%, respectively). Both the mean gestational age and the mean birth weight were significantly greater (P < 0.001) for LT recipients versus KT recipients (36.5 versus 35.6 weeks and 2866 versus 2420 g). Although pregnancy after LT is feasible, the complication rates are relatively high and should be considered during patient counseling and clinical decision making. More case and center reports are necessary so that information on post-LT pregnancy outcomes and complications can be gathered to improve the clinical management of pregnant LT recipients. Continued reporting to active registries is highly encouraged at the center level.
目前,美国有大约 14000 名育龄期妇女在接受肝移植(LT)后存活,每年还有 500 名妇女接受 LT。尽管 LT 改善了晚期肝病妇女的生殖功能,但广泛量化的妊娠结局和母婴风险尚未得到确定。为了获得更具普遍性的推论,我们对 2000 年至 2011 年间发表的报告 LT 受者妊娠相关结局的文章进行了系统回顾和荟萃分析。在 578 项独特的研究中,有 8 项符合纳入标准,这些研究代表了 306 名 LT 受者中的 450 例妊娠。LT 后活产率[76.9%,95%置信区间(CI)=72.7%-80.7%]高于美国一般人群的活产率(66.7%),但与肾移植(KT)后活产率(73.5%)相似。LT 后流产率(15.6%,95%CI=12.3%-19.2%)低于一般人群的流产率(17.1%),但与 KT 后流产率(14.0%)相似。先兆子痫(21.9%,95%CI=17.7%-26.4%)、剖宫产分娩(44.6%,95%CI=39.2%-50.1%)和早产(39.4%,95%CI=33.1%-46.0%)的发生率高于美国一般人群(分别为 3.8%、31.9%和 12.5%),但低于 KT 后(分别为 27.0%、56.9%和 45.6%)。LT 受者的平均孕龄和平均出生体重均显著大于(P<0.001)KT 受者(分别为 36.5 周和 2866 克与 35.6 周和 2420 克)。尽管 LT 后妊娠是可行的,但并发症发生率相对较高,在患者咨询和临床决策中应予以考虑。需要更多的病例和中心报告,以便收集 LT 后妊娠结局和并发症的信息,以改善对妊娠 LT 受者的临床管理。中心一级应高度鼓励继续向活跃的登记处报告。